Pediatric Parents Virtual Support Group - 2022 September
Event Date:
Tue, 09/13/2022 - 7:30pm (EDT)
This virtual support group is designed to support pediatric parents whose children have been diagnosed with
Bone Marrow Disease(s):
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
This virtual support group is designed to support pediatric parents whose children have been diagnosed with
AAMDSIF is pleased to announce that we will host a support group for patients who have undergone transplant for
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
Carlo Dufour works in G.Gaslini Research Children’s Hospital, Genova, Italy, the largest, multi specialist pediatric hospital of the country, where he chairs the Hemo-Onco- HSCT Department and the Hematology Unit where have seat the national Registry of
BOSTON--(BUSINESS WIRE)--Aug. 1, 2022-- Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment of patients with blood cancers in need of an allogenic hematopoietic stem cell transplant.
Find the recordings for the 2022 Memphis Patient and Family Hybrid Conference here:
In this conference session, Dr. Sharma discusses what causes severe
In this two-part conference session, Dr. Brion Randolph discusses the process of transplant as a modality for treating
In this conference session, Dr. Thota discusses what a patient may experience and expect when diagnosed with
In this conference session, Dr. Ashkay Sharma discusses what causes severe
